| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |